APTR and prostate cancer: Consistent with our lncRNA screening results, knockdown of APTR by two different siRNAs not only decreased proliferation of MCF10A, but also PC3 (prostate cancer cell with mutant p53) cells to the same extent as knockdown of ORC2 (Figure 1D and E).